Corrado Advisors, LLC Bristol Myers Squibb CO Transaction History

Corrado Advisors, LLC

$130 Million
Q2 2024

A detailed history of Corrado Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Corrado Advisors, LLC holds 33,136 shares of BMY stock, worth $1.66 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

33,136

Previous 34,441 3.79%

Holding current value

$1.66 Million

Previous $1.87 Million 26.3%

% of portfolio

1.06%

Previous 1.46%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$40.25 - $52.99 $52,526 - $69,151	-1,305 Reduced 3.79%	33,136 $1.38 Million
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $42,750 - $48,470	-891 Reduced 2.52%	34,441 $1.87 Million
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $63,799 - $76,130	-1,316 Reduced 3.59%	35,332 $1.81 Million
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $41,101 - $45,958	710 Added 1.98%	36,648 $2.13 Million
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $11,786 - $13,086	-185 Reduced 0.51%	35,938 $2.3 Million
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $68,075 - $77,213	1,036 Added 2.95%	36,123 $2.5 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $38,417 - $45,491	561 Added 1.62%	35,087 $2.52 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $57 - $34,193	-445 Reduced 1.27%	34,526 $2.45 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $3,848 - $4,238	53 Added 0.15%	34,971 $2.69 Million
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $41,806 - $50,129	680 Added 1.99%	34,918 $2.55 Million
Q4 2021 Jan 14, 2022	BUY	$53.63 - $62.52 $33,733 - $39,325	629 Added 1.87%	34,238 $2.14 Million
Q3 2021 Oct 13, 2021	BUY	$59.17 - $69.31 $17,632 - $20,654	298 Added 0.89%	33,609 $1.99 Million
Q2 2021 Jul 20, 2021	BUY	$61.91 - $67.42 $183,872 - $200,237	2,970 Added 9.79%	33,311 $2.23 Million
Q1 2021 Apr 15, 2021	SELL	$59.34 - $66.74 $43,911 - $49,387	-740 Reduced 2.38%	30,341 $1.92 Million
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $131,012 - $148,460	-2,269 Reduced 6.8%	31,081 $1.93 Million
Q3 2020 Oct 07, 2020	SELL	$57.43 - $63.64 $23,661 - $26,219	-412 Reduced 1.22%	33,350 $2.01 Million
Q2 2020 Jul 07, 2020	SELL	$54.82 - $64.09 $399,089 - $466,575	-7,280 Reduced 17.74%	33,762 $1.99 Million
Q1 2020 Apr 06, 2020	SELL	$46.4 - $67.43 $641,944 - $932,894	-13,835 Reduced 25.21%	41,042 $2.29 Million
Q4 2019 Jan 15, 2020	SELL	$49.21 - $64.19 $191,426 - $249,699	-3,890 Reduced 6.62%	54,877 $3.52 Million
Q3 2019 Oct 08, 2019	SELL	$42.77 - $50.71 $32,291 - $38,286	-755 Reduced 1.27%	58,767 $2.98 Million
Q2 2019 Jul 10, 2019	BUY	$44.62 - $49.34 $1.28 Million - $1.42 Million	28,726 Added 93.28%	59,522 $2.7 Million
Q1 2019 Apr 03, 2019	BUY	$45.12 - $53.8 $1.39 Million - $1.66 Million	30,796 New	30,796 $1.47 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $107B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corrado Advisors, LLC with notifications on news.

Account

Corrado Advisors, LLC Bristol Myers Squibb CO Transaction History